[MNPR] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
26-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -39.06%
YoY- -24.65%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,896 -2,681 -2,128 -1,207 -962 -714 -320 44.33%
Tax -14 -1 -2,261 -1,225 -72 -737 1 -
NP -2,883 -2,681 -2,128 -1,207 -890 -714 -320 44.22%
Tax Rate - - - - - - - -
Total Cost 2,883 2,681 2,128 1,207 890 714 320 44.22%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.22 -0.21 -0.19 -0.11 -0.09 -0.07 -0.04 32.84%
EPS Diluted -0.22 -0.21 -0.19 -0.11 -0.09 -0.07 -0.03 39.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.